12/03/2024
4:21 PM | Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
7:22 AM | Amylyx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:07 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
6:24 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
9:56 AM | Amylyx Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G | |
10/25/2024
4:38 PM | Amylyx Pharmaceuticals (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
10/17/2024
8:12 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/02/2024
5:48 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
5:50 PM | Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
5:53 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
5:53 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
4:56 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
4:39 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
4:30 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:55 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4/A | |
09/05/2024
6:26 PM | Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
5:49 PM | Amylyx Pharmaceuticals (Subject)
TCG Crossover GP II, LLC (Filed by)
| Form SC 13G | |
08/08/2024
6:09 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:14 AM | Amylyx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/10/2024
6:09 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:32 PM | Amylyx Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
06/21/2024
4:07 PM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
3:42 PM | Amylyx Pharmaceuticals (Issuer)
Quimi Daphne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:44 PM | Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:49 PM | Amylyx Pharmaceuticals (Issuer)
Zeiher Bernhardt G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:50 PM | Amylyx Pharmaceuticals (Issuer)
Firestone Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:52 PM | Amylyx Pharmaceuticals (Issuer)
FONTEYNE PAUL R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:36 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:37 PM | Amylyx Pharmaceuticals (Issuer)
Quimi Daphne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:05 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:12 AM | Amylyx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
6:12 AM | Amylyx Pharmaceuticals (Filer)
| Form DEFA14A | |
04/24/2024
6:19 AM | Amylyx Pharmaceuticals (Filer)
| Form ARS | |
04/24/2024
6:07 AM | Amylyx Pharmaceuticals (Filer)
| Form DEF 14A | |
04/18/2024
7:19 PM | Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
7:20 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
7:20 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
7:21 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
7:23 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:19 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
6:10 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
How to piss off your liberal friends… and profit from it (Ad) Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X.
And people are slowly starting to wake up to the Deep State’s lies. To get the full details on the fake “energy crisis” of America, watch this now |
03/15/2024
3:31 PM | Amylyx Pharmaceuticals (Issuer)
Zeiher Bernhardt G (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/15/2024
3:35 PM | Amylyx Pharmaceuticals (Issuer)
Zeiher Bernhardt G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
8:18 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
7:44 AM | Amylyx Pharmaceuticals (Subject)
Panacea Innovation Ltd (Filed by)
| Form SC 13G | |
03/08/2024
6:10 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
5:44 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
5:13 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
5:20 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
5:22 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:22 AM | Amylyx Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/22/2024
6:08 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:36 PM | Amylyx Pharmaceuticals (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
9:24 AM | Amylyx Pharmaceuticals (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G/A | |
02/14/2024
6:15 AM | Amylyx Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
01/29/2024
4:25 PM | Amylyx Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G | |
01/29/2024
3:38 PM | Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
3:50 PM | Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
4:04 PM | Amylyx Pharmaceuticals (Issuer)
Yeramian Patrick D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
4:10 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
4:11 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
4:11 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
3:37 PM | Amylyx Pharmaceuticals (Issuer)
Firestone Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
